Anna Williamson is an accomplished executive in the pharmaceutical industry, currently serving as Executive Director and UK Partnering Lead at Roche Pharma Partnering since August 2019, while also holding the position of Senior Director and Head of UK Business Development. In addition to roles at Roche, Anna is a Board Member of the BioIndustry Association and serves as a Board Observer and Investment Committee Member at Start Codon. Prior experience includes a substantial tenure at Genentech from 2004 to 2021, where Anna held leadership positions in Oncology Business Development, and a background in technology transfer at the University of California Office of Technology Transfer. Academically, Anna holds a Ph.D. in Neuroscience and an MA in Natural Sciences (Neuroscience), both obtained from the University of Cambridge.